Sort   by:  
 Page size 
UnknownNeoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial.
Not available
S-EPMC11021407 | biostudies-literature
UnknownReal-world practice of conversion surgery for unresectable hepatocellular carcinoma - a single center data of 26 consecutive patients.
Not available
S-EPMC10199571 | biostudies-literature
UnknownHepatic artery infusion chemotherapy combined with camrelizumab and apatinib as conversion therapy for patients with unresectable hepatocellular carcinoma: a single-arm exploratory trial.
Not available
S-EPMC12056981 | biostudies-literature
UnknownEfficacy and safety of radiotherapy to delay second-line systemic therapy in patients with oligoprogressive hepatocellular carcinoma: study protocol of a multicentre, single-arm, phase II trial.
Not available
S-EPMC12035168 | biostudies-literature
Sort   by:  
 Page size